The Sentio System: Post-market Evaluation of Safety and Performance in Adolescents
NCT06844071 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 25
Last updated 2025-09-22
Summary
This study is a post-market, multicentre, prospective, single arm investigation aimed to systematically collect safety and performance data on the Sentio system, when used as intended for adolescents (12-17 years inclusive).
Conditions
Sponsors & Collaborators
-
Oticon Medical
lead INDUSTRY
Eligibility
- Min Age
- 12 Years
- Max Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-08-15
- Primary Completion
- 2027-04-30
- Completion
- 2027-08-31
Countries
- United States
Study Locations
More Related Trials
-
Otoferlin Gene-mediated Hearing Loss Natural History Study
NCT05572073 ·Status: RECRUITING
-
Investigation to Evaluate the Safety and Effectiveness of Cochlear Implantation in Children and Adults With Unilateral Hearing Loss/Single-sided Deafness
NCT05318417 ·Status: RECRUITING ·Phase: NA
-
Clinical Performance of a New Implant System for Bone Conduction Hearing
NCT03086135 ·Status: COMPLETED ·Phase: NA
-
Cochlear Implantation Among Adults and Older Children With Unilateral or Asymmetric Hearing Loss
NCT02105441 ·Status: COMPLETED
-
The EarLens Contact Hearing Device (CHD) Spectrum Study
NCT02470494 ·Status: COMPLETED ·Phase: NA
-
An Investigator Initiated Study for OTOV101N+OTOV101C Injection
NCT05901480 ·Status: UNKNOWN ·Phase: NA
-
Clinical Performance, Safety and Patient Reported Outcomes of an Active Osseointegrated Steady-State Implant System
NCT04041700 ·Status: COMPLETED ·Phase: NA
-
Cochlear Implants for Adults With Single-sided Deafness
NCT02259192 ·Status: UNKNOWN ·Phase: NA
-
AM-101 in the Treatment of Post-Acute Tinnitus 1
NCT01934010 ·Status: COMPLETED ·Phase: PHASE3
-
Long Term Follow-up Study of AAVAnc80-hOTOF Gene Therapy
NCT06696456 ·Status: ENROLLING_BY_INVITATION
-
First in Human Safety Study of FX-345 in Adults With Sensorineural Hearing Loss
NCT05664100 ·Status: TERMINATED ·Phase: PHASE1
-
Efficacy of AM 101 in Patients With Acute Inner Ear Tinnitus
NCT00860808 ·Status: COMPLETED ·Phase: PHASE2
-
OTO-313 in Subjects With Unilateral Subjective Tinnitus
NCT04829214 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of AUT00063 Versus Placebo in Age-Related Hearing Loss
NCT02345031 ·Status: COMPLETED ·Phase: PHASE2
-
Clinical Performance of the Osia 3 Sound Processor Compared With the Osia 2 Sound Processor in Adult Osia Implant Users
NCT06338670 ·Status: COMPLETED ·Phase: NA
-
Evaluation of the CochSyn Device in Clinical Practice
NCT07091071 ·Status: COMPLETED ·Phase: NA
-
A Study of DB-OTO, an Adeno-Associated Virus (AAV) Based Gene Therapy, in Children/Infants With Hearing Loss Due to Otoferlin Mutations
NCT05788536 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Gene Therapy Trial for Otoferlin Gene-mediated Hearing Loss
NCT05821959 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Open Label Study of OTO-104 in Subjects With Meniere's Disease
NCT02740387 ·Status: TERMINATED ·Phase: PHASE2
-
AM-101 in the Treatment of Acute Tinnitus 3
NCT02040194 ·Status: COMPLETED ·Phase: PHASE3
-
Implantation of the Cochlear™ Nucleus® Hybrid S Round Window (S-RW) in Adults
NCT02638883 ·Status: COMPLETED
-
AM-101 in the Treatment of Post-Acute Tinnitus 2
NCT02040207 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy of SENS 401 in Subjects With Severe or Profound Sudden Sensorineural Hearing Loss
NCT03603314 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
A 6-Month Extension Study of OTO-104 in Meniere's Disease
NCT02706730 ·Status: TERMINATED ·Phase: PHASE3
-
Expanded Indications in the MED-EL Pediatric Cochlear Implant Population
NCT03900897 ·Status: COMPLETED ·Phase: NA